Prof. Giorgi Pkhakadze, MD, MPH, PhD
Oral GLP-1 Drug Achieves 11.3% Weight Loss in Phase 2 Trial
Phase 2b trial shows oral GLP-1 drug aleniglipron achieved 11.3% weight loss in 230 adults with obesity. Results suggest oral…
AI-Enhanced Scans and Immune-Targeting Drugs Transform Heart Inflammation Detection
AI-enhanced imaging and immune-targeting drugs are revolutionizing cardiac inflammation detection and treatment. Nature Medicine reports on paradigm shift in cardiovascular…
Spinal Cord Stimulation Shows Promise for Stroke Recovery in Small Trial
Small clinical trial shows epidural spinal cord stimulation safely improved arm function in seven chronic stroke patients. Larger studies needed…
Multi-cancer blood tests identify missed cancers in 20% of symptomatic patients, Lancet study finds
New blood test technology could help identify one in five cancers that would otherwise be missed in symptomatic patients. Lancet…
Eric Edwards, Pioneer of UK Kidney Transplantation, Dies
Eric Edwards, the pioneering British urologist who performed the first cadaver kidney transplant in the UK, has died. His groundbreaking…
UK Approves 47 New Pharmaceutical Manufacturing and Wholesale Dealer Licences in Latest MHRA Review
UK's MHRA has granted 47 new pharmaceutical manufacturing and wholesale dealer licences in its latest regulatory review. The licensing expansion…
MHRA Updates Register of Licensed Manufacturing Sites for Human and Veterinary Medicines
The UK's MHRA has published an updated register of licensed manufacturing sites for human and veterinary medicines, providing transparency in…
Mental health therapies judged by wrong research standards, Manchester analysis reveals
New University of Manchester analysis argues psychological therapies are inappropriately evaluated using drug trial methods. This methodological mismatch may limit…